Search Results 161-170 of 18172 for creatine evidence

1. A Study of Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia, or Refractory or Relapsed Acute Myelogenous Leukemia - Mayo Clinic

   ... evidence of residual AML (≥ 0.1%) at the end of Induction I; or if a ... Creatinine clearance or radioisotope glomerular filtration rate at least 60 mL/min OR ...

2. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   * Creatinine clearance or radioisotope glomerular ... creatinine (mg/dL) 1 month to \< 6 months ... * No evidence of dyspnea at rest, no exercise ...

3. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ... evidence of disease progression; Must have had ... proof of radiological progression ... Creatinine ≤ 1.5 × institutional upper limit of normal OR creatinine ...

4. Vocal cord paralysis - Symptoms and causes - Mayo Clinic

   There's some evidence that infection with COVID-19 may cause vocal cord paralysis. Neurological conditions. Certain neurological conditions, such as ...

5. First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects with Acute Myelogenous Leukemia and Selected B-cell Cancers - Mayo Clinic

   (For DLBCL): Inadequate renal function defined as creatinine clearance (by Cockcroft-Gault formula) < 60 mL/min ... evidence of acute ischemia; Myelodysplastic ...

6. A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... evidence of treatment efficacy. Participation eligibility. Participant ... Calculated creatinine clearance (CrCl) ≥ 30 mL/min (Cockroft & Gault formula ...

7. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

   Serum creatinine ≤ 1.5 x ULN or creatinine ... (140 - age) x (weight in kg) x (0.85 if female)/ 72 x (serum creatinine in mg/dL) ... Evidence for changes, ...

8. Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working - Mayo Clinic

   - Creatinine ≤ 1.5 * upper limit of normal (ULN) (within ≤ 28 days prior to registration). * If creatinine ... - For patients with evidence of chronic hepatitis ...

9. A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial - Mayo Clinic

   ... evidence of recurrent disease as determined by the investigator. ... Patient must not have previously had evidence ... Creatinine ≤ institutional ULN OR calculated ...

10. Evaluate The Effect Of Aclidinium Bromide On Long-term Cardiovascular Safety And Exacerbations In Moderate To Very Severe COPD Patients. - Mayo Clinic

    Evidence of renal dysfunction (eGFR < 60) and microalbuminuria (eGFR is ... creatinine on a spot urine or ≥30 mg creatinine on a 24hr urine test). 5 ...